CymitQuimica logo
Células madre y Derivados

Células madre y Derivados

Los inhibidores de células madre son compuestos que se dirigen específicamente a las vías de señalización y proteínas involucradas en el mantenimiento, diferenciación y proliferación de células madre. Estos inhibidores son cruciales para comprender la biología de las células madre y para desarrollar estrategias que permitan manipularlas con fines terapéuticos, como en la medicina regenerativa y el tratamiento del cáncer. Al controlar el destino de las células madre, estos inhibidores pueden ayudar a guiar la diferenciación de células madre en tipos celulares específicos o prevenir el crecimiento celular no deseado. En CymitQuimica, ofrecemos una selección de inhibidores de células madre de alta calidad para apoyar su investigación en biología de células madre, biología del desarrollo y medicina regenerativa.

Subcategorías de "Células madre y Derivados"

Mostrar 2 subcategorías más

Se han encontrado 416 productos para "Células madre y Derivados".

Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
productos por página.
  • TGFβRII-IN-3

    CAS:
    TGFβRII-IN-3 (Compound 2r) is a selective inhibitor of the TGFβ type II receptor (TGFβ RII) with an IC50 of 4.1 μM. It inhibits TGFβ signaling by promoting protein degradation of TGFβ RII. Additionally, TGFβRI-IN-7 can block the transition from endothelial to mesenchymal states and inhibit cell migration, making it useful for cancer research.
    Fórmula:C27H27F3N2O2
    Forma y color:Solid
    Peso molecular:468.51

    Ref: TM-T209758

    10mg
    A consultar
    50mg
    A consultar
  • JAK3-IN-18

    CAS:
    JAK3-IN-18 is a selective and orally active dual inhibitor targeting JAK3 and TEC, with IC50 values of 0.5391 nM and 12.40 nM, respectively. It demonstrates remarkable selectivity for AK1, AK2, and TYK2, with selectivity ratios exceeding 10,000-fold. JAK3-IN-18 exhibits exceptional therapeutic efficacy in a mouse model of experimental autoimmune encephalomyelitis and is applicable for multiple sclerosis research.
    Fórmula:C18H16FN5O
    Peso molecular:337.35

    Ref: TM-T211808

    10mg
    A consultar
    50mg
    A consultar
  • JAK3-IN-7

    CAS:
    JAK3-IN-7 is a potent and selective JAK3 inhibitor (IC50<0.01 μM) for the treatment of rejection in organ transplantation, graft-versus-host reaction after
    Fórmula:C17H20N6O
    Pureza:98.81%
    Forma y color:Yellow Solid
    Peso molecular:324.38

    Ref: TM-T10009

    1mg
    411,00€
    5mg
    954,00€
  • DAPM

    CAS:
    DAPM (gamma-Secretase Inhibitor XVI) is a Notch pathway inhibitor with anticancer activity and antiproliferative effects.
    Fórmula:C20H20F2N2O4
    Pureza:99.76%
    Forma y color:White Solid
    Peso molecular:390.38

    Ref: TM-T86161

    1mg
    74,00€
    5mg
    161,00€
    10mg
    231,00€
    25mg
    389,00€
  • (+)-ITD-1

    CAS:
    (+)-ITD-1 is an inhibitor of TGF-β, effectively inhibiting TGF-β2 with an IC50 of 0.46 μM. It promotes the degradation of the TGF-β type II receptor (TGFBR2) and the differentiation of cardiomyocytes. Additionally, it suppresses the formation of the mesoderm during the early differentiation of mouse embryonic stem cells (mESCs).
    Fórmula:C27H29NO3
    Forma y color:Solid
    Peso molecular:415.52

    Ref: TM-T201672

    10mg
    A consultar
    50mg
    A consultar
  • JAK2-IN-11

    CAS:
    JAK2-IN-11 is a JAK2 kinase inhibitor with potent antitumor activity, exhibiting an IC50 of ≤10 nM against JH2 BIND WT/V617F. This compound effectively suppresses tumor growth.
    Fórmula:C31H31F3N8O4
    Forma y color:Solid
    Peso molecular:639.64

    Ref: TM-T201601

    10mg
    A consultar
    50mg
    A consultar
  • PF-06648671

    CAS:
    PF-06648671 is a γ-secretase modulator for the treatment of neurodegenerative and/or neurological disorders.
    Fórmula:C25H23ClF4N4O3
    Pureza:98%
    Forma y color:Solid
    Peso molecular:538.92

    Ref: TM-T24621

    25mg
    A consultar
    50mg
    A consultar
    100mg
    A consultar
  • PF-06263276

    CAS:
    PF-06263276 selectively inhibits pan-JAK with IC50: JAK1 (2.2 nM), JAK2 (23.1 nM), JAK3 (59.9 nM), TYK2 (29.7 nM).
    Fórmula:C31H31FN8O2
    Pureza:98%
    Forma y color:Solid
    Peso molecular:566.63

    Ref: TM-T16488

    2mg
    95,00€
    5mg
    172,00€
    50mg
    672,00€
    100mg
    1.071,00€
  • Tyk2-IN-3

    CAS:
    Tyk2-IN-3 is an inhibitor of Tyk2 pseudokinase (IC50: 485 nM).
    Fórmula:C25H24N6O3S2
    Pureza:98%
    Forma y color:Solid
    Peso molecular:520.63

    Ref: TM-T13233

    25mg
    A consultar
    50mg
    A consultar
    100mg
    A consultar
  • (3S,4R)-Tofacitinib

    CAS:
    (3S,4R)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib is a JAK3 inhibitor(IC50 : 1 nM).
    Fórmula:C16H20N6O
    Pureza:98%
    Forma y color:Solid
    Peso molecular:312.37

    Ref: TM-T13427

    25mg
    1.639,00€
    50mg
    2.142,00€
    100mg
    2.790,00€
  • AZ-3

    CAS:
    AZ-3 is a potent and selective JAK1 inhibitor (IC50: 34 nM).
    Fórmula:C20H28FN7
    Pureza:98%
    Forma y color:Solid
    Peso molecular:385.48

    Ref: TM-T10424

    25mg
    A consultar
    50mg
    A consultar
    100mg
    A consultar
  • TEAD-IN-1

    CAS:
    TEAD-IN-1 (Compound 2) is an effective inhibitor of TEAD auto-palmitoylation with an IC50 of 603 nM. It enhances the interaction between TEAD and VGLL4, while diminishing the interaction between YAP and TEAD. TEAD-IN-1 is applicable for cancer research.
    Fórmula:C15H20F2N2O3S
    Forma y color:Solid
    Peso molecular:346.393

    Ref: TM-T204883

    10mg
    A consultar
    50mg
    A consultar
  • lirucitinib

    CAS:
    Lirucitinib is a JAK inhibitor known for its anti-inflammatory properties.
    Fórmula:C16H25N5OS
    Forma y color:Solid
    Peso molecular:335.468

    Ref: TM-T205259

    10mg
    A consultar
    50mg
    A consultar
  • M3686

    CAS:
    M3686 (Compound 29) is a potent and selective TEAD1 inhibitor with an IC50 value of 51 nM. It exhibits weaker binding activity toward TEAD3. M3686 significantly inhibits the cellular activity of YAP-dependent NCI-H226 cell lines, with an IC50 value of 0.06 μM, and demonstrates strong antitumor effects in the NCI-H226 xenograft model.
    Fórmula:C21H18F3N5O2
    Forma y color:Solid
    Peso molecular:429.395

    Ref: TM-T205477

    10mg
    A consultar
    50mg
    A consultar
  • TGFβRI-IN-3

    CAS:
    TGFβRI-IN-3 inhibits TGFβR1 with an IC 50 of 0.79 nM with 2000-fold selectivity against MAP4K4.
    Fórmula:C28H23N3O2S
    Pureza:99.85%
    Forma y color:Solid
    Peso molecular:465.57

    Ref: TM-T9523

    1mg
    84,00€
    5mg
    177,00€
    1mL*10mM (DMSO)
    177,00€
    10mg
    281,00€
    25mg
    552,00€
    50mg
    859,00€
    100mg
    1.234,00€
    500mg
    2.457,00€
  • JDTic

    CAS:
    JDTic, a 4-phenylpiperidine derivative distantly related to analgesics like meperidine and ketobemidone and more closely to the mu opioid antagonist alvimopan, exhibits a notably long duration of action, maintaining effects in animals for weeks following a single dose. This duration is not due to irreversible binding to the kappa opioid receptor but rather to altered activity of c-Jun N-terminal kinases. As a highly selective antagonist for the κ-opioid receptor, without influencing the μ- or δ-opioid receptors, JDTic has shown potential in animal studies for producing antidepressant and anxiolytic effects. It also demonstrates promise in treating addiction to substances such as cocaine and morphine, distinguishing itself structurally from other kappa antagonists like norbinaltorphimine.
    Fórmula:C28H39N3O3
    Forma y color:Solid
    Peso molecular:465.63

    Ref: TM-T11721

    5mg
    1.594,00€
    50mg
    3.222,00€
    100mg
    4.410,00€